Brooke advises U.S. and international pharma and biotech companies on patent strategy and portfolio management.

She handles patent procurement and licensing, counseling clients at all stages of the process, from product development through the clinical phase and approval. Brooke also provides due diligence counseling to support financing or target acquisition, and conducts patentability, freedom-to-operate and landscape analyses. In addition, she supports patent litigation efforts.

Brooke has drafted and prosecuted patents involving antibodies, enzyme replacement therapies, siRNAs, viral vectors, cell therapies, fusion proteins, small molecules and gene editing, as well as methods of treatment, medical uses and clinical protocols.